Analyst Recommendations

Outperform Recommendation Issued On TCOM By Bernstein
Bernstein analyst issues OUTPERFORM recommendation for TCOM on November 4, 2024 10:48AM ET. TCOM was trading at $67.24 at issue of the analyst recommendation.The overall analyst consensus :...

November 5, 2024   TCOM 4.63%

Hold Recommendation Issued On TTE By Cowen & Co.
Cowen & Co. analyst issues HOLD recommendation for TTE on November 4, 2024 02:16PM ET. The previous analyst recommendation was Hold.TTE was trading at $62.99 at issue of...

November 5, 2024   TTE -3.68%

Hold Recommendation Issued On NA By Deutsche Bank
Deutsche Bank analyst issues HOLD recommendation for NA on November 4, 2024 02:56PM ET. The previous analyst recommendation was Hold.NA was trading at $4.6 at issue of the...

November 5, 2024   NA -8.11%

Neutral Recommendation Issued On CRTO By Susquehanna
Susquehanna analyst issues NEUTRAL recommendation for CRTO on October 31, 2024 08:35AM ET. The previous analyst recommendation was Neutral.CRTO was trading at $33.59 at issue of the analyst...

October 31, 2024   CRTO -0.32%

Buy Recommendation Issued On MDXH By Lake Street
Lake Street analyst issues BUY recommendation for MDXH on October 31, 2024 08:43AM ET. MDXH was trading at $2.04 at issue of the analyst recommendation.The overall analyst consensus...

October 31, 2024   MDXH -2.28%

Buy Recommendation Issued On STM By Craig-Hallum
Craig-Hallum analyst issues BUY recommendation for STM on October 31, 2024 08:49AM ET. The previous analyst recommendation was Buy.STM was trading at $27.07 at issue of the analyst...

October 31, 2024   STM -2.26%

Outperform Recommendation Issued On AVDL By Oppenheimer
Oppenheimer analyst issues OUTPERFORM recommendation for AVDL on October 31, 2024 07:53AM ET. The previous analyst recommendation was Outperform.AVDL was trading at $12.91 at issue of the analyst...

October 31, 2024   AVDL -0.45%

Neutral Recommendation Issued On GSK By Guggenheim
Guggenheim analyst issues NEUTRAL recommendation for GSK on October 31, 2024 05:02AM ET. The previous analyst recommendation was Buy.GSK was trading at $37.01 at issue of the analyst...

October 31, 2024   GSK 0.03%

Outperform Recommendation Issued On JP By CLSA
CLSA analyst issues OUTPERFORM recommendation for JP on October 31, 2024 12:28AM ET. The previous analyst recommendation was Outperform.JP was trading at $0.38 at issue of the analyst...

October 31, 2024   GSK 0.03%

Outperform Recommendation Issued On BRFS By Santander
Santander analyst issues OUTPERFORM recommendation for BRFS on October 30, 2024 09:22PM ET. BRFS was trading at $4.47 at issue of the analyst recommendation.The overall analyst consensus :...

October 30, 2024   BRFS 7.87%